New research reveals that popular diabetes and weight-loss drugs may also protect the kidneys. This groundbreaking study, ...

The likes of Wegovy and Ozempic could reduce the risk of kidney deterioration and failure by a fifth, a major study found.

Sodium-glucose cotransporter-2 (SGLT2) inhibitors are a newer type of medication used to help manage diabetes. While these ...

A new class of weight-loss drugs touted as a revolutionary breakthrough in obesity management have received global attention, ...

Compared with standard AUD medications, the use of semaglutide and liraglutide was linked to a lower risk for alcohol use ...

Another day, another headline suggesting the new breed of diabetes and weight loss drugs offer hope for another chronic ...

Ozempic, Wegovy and other GLP-1 drugs have been shown to curb alcoholism, a new study suggests. Researchers explain why ...

Joe Biden wants diabetes drugs that aid weight loss and treat obesity, such as Wegovy, to fall under Medicare and Medicaid.

By Dr. Sushama R. Chaphalkar, PhD. Research shows how common diabetes medications are transforming asthma care by reducing ...

Most patients still need to be managed by oral medications to treat diabetes and not injections, at least in the early stages ...

The combined reduction in the risk of kidney failure, worsening kidney function and death due to kidney disease was 19%, ...

The Biden administration wants to expand coverage of anti-obesity medications to millions on Medicare, Medicaid.